A new study led by NYU Langone Health researchers has found that cancer cells are better able to resist treatments when they ...

Scientists from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute have deciphered a key mechanism ...

Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it is properly activated. In many patients, however, this response is too weak ...

Among the challenges in treating disease, including cancer, is wiping out malignancies, infection, contaminants or other pathologies, without destroying healthy tissue.

The body’s “killer” T cells don’t just attack—they strike with astonishing precision, forming a tiny, highly organized ...

When activated by its target, the newly characterized molecule rips the genome apart, a lethal move that researchers can ...

The first clinical trial to test the tumour-fighting power of a stem-cell-like class of long-lived immune cells suggests that ...

Researchers have reported two major immunology advances: Weill Cornell Medicine scientists found that activated T cells secrete DNA-filled vesicles that can enhance immune responses against tumors, ...

Daraxonrasib shows promising results in treating pancreatic cancer, potentially revolutionizing care with its effectiveness ...

ImmunityBio will deliver what it calls the world’s first AI-powered NK-cell manufacturing robot this month, aiming to automate production of cancer-killing immune cells. Founder Patrick Soon-Shiong ...